These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19078842)

  • 1. First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening.
    Ovaska H; Viljoen A; Puchnarewicz M; Button J; Ramsey J; Holt DW; Dargan PI; Wood DM
    Eur J Emerg Med; 2008 Dec; 15(6):354-6. PubMed ID: 19078842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fatal intoxication of 2,5-dimethoxy-4-chloroamphetamine: a case report.
    Barnett RY; Baker DD; Kelly NE; McGuire CE; Fassette TC; Gorniak JM
    J Anal Toxicol; 2014 Oct; 38(8):589-91. PubMed ID: 25217551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged Psychosis With Catatonia due to 2,5-Dimethoxy-4-Bromoamphetamine: Case Report and Literature Review.
    Scarella TM; Teslyar P
    Psychosomatics; 2019; 60(6):599-602. PubMed ID: 30583875
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose.
    Balíková M
    Forensic Sci Int; 2005 Oct; 153(1):85-91. PubMed ID: 15979834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Ewald AH; Fritschi G; Bork WR; Maurer HH
    J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.
    Ewald AH; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):170-4. PubMed ID: 17632045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recreational drugs and their neurological consequences.
    Enevoldson TP
    J Neurol Neurosurg Psychiatry; 2004 Sep; 75 Suppl 3(Suppl 3):iii9-15. PubMed ID: 15316039
    [No Abstract]   [Full Text] [Related]  

  • 8. Study on metabolites of 2,5-dimethoxy-4-bromamphetamine (DOB) in human urine using gas chromatography-mass spectrometry.
    Beránková K; Balíková M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):465-8. PubMed ID: 16601811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project.
    Bäckberg M; Lindeman E; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Jan; 53(1):46-53. PubMed ID: 25422862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phantom menace: novel psychoactive substances and the UK Armed Forces.
    Hunter AH; Ayres T; Moreland N; Cox A
    J R Army Med Corps; 2018 Nov; 164(6):450-457. PubMed ID: 29934414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nopaine no gain: recreational ethylphenidate toxicity.
    Bailey GP; Ho JH; Hudson S; Dines A; Archer JR; Dargan PI; Wood DM
    Clin Toxicol (Phila); 2015 Jun; 53(5):498-9. PubMed ID: 25871917
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY.
    Wood DM; Looker JJ; Shaikh L; Button J; Puchnarewicz M; Davies S; Lidder S; Ramsey J; Holt DW; Dargan PI
    J Med Toxicol; 2009 Dec; 5(4):226-9. PubMed ID: 19876858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicokinetics of the Synthetic Cathinone α-Pyrrolidinohexanophenone.
    Fujita Y; Mita T; Usui K; Kamijo Y; Kikuchi S; Onodera M; Fujino Y; Inoue Y
    J Anal Toxicol; 2018 Jan; 42(1):e1-e5. PubMed ID: 29036640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paramethoxymethamphetamine].
    Westin AA; Brede WR
    Tidsskr Nor Laegeforen; 2011 Oct; 131(20):2008. PubMed ID: 22016127
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous determination of new thioamphetamine designer drugs in plasma by capillary electrophoresis coupled with mass spectrometry.
    Boatto G; Nieddu M; Pirisi MA; Dessì G
    Rapid Commun Mass Spectrom; 2007; 21(22):3716-20. PubMed ID: 17955568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland.
    Liakoni E; Dolder PC; Rentsch K; Liechti ME
    Swiss Med Wkly; 2015; 145():w14166. PubMed ID: 26218967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]).
    Lidder S; Dargan P; Sexton M; Button J; Ramsey J; Holt D; Wood D
    J Med Toxicol; 2008 Sep; 4(3):167-9. PubMed ID: 18821489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromo-DMA: the Australasian hallucinogen?
    Buhrich N; Morris G; Cook G
    Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromo-DMA: new hallucinogenic drug.
    Delliou D
    Med J Aust; 1980 Jan; 1(2):83. PubMed ID: 7360100
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
    Wood DM; Button J; Lidder S; Ramsey J; Holt DW; Dargan PI
    J Med Toxicol; 2008 Dec; 4(4):254-7. PubMed ID: 19031377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.